Skip to main content
Use this button to show the site search bar.
Polypharmacy: Manage Medicines
Polypharmacy: Manage Medicines
Search for toolkits, guidelines and other information:
Search
Menu
Home
About
Contact us
Implementation
Notifications
Home
Back
Respiratory prescribing (in development)
Environmental impact of inhalers
Environmental impact of inhalers
Summary of recommendations for environmental considerations of respiratory prescribing
Inhaler prescribing
The most environmentally friendly inhaler is the one that the patient can, will and does use
Prescribing issues to consider
Area wide projects to promote inclusion of environmental focus for local formularies
CO2 emissions in Scotland
Case study
Respiratory prescribing (in development)
Feedback
Key messages
Asthma
Decision aid: When is a dry powder inhaler (DPI) suitable for a patient with asthma?
Chronic obstructive pulmonary disease (COPD)
Bronchiectasis, persistent bacterial bronchitis and chronic bronchial sepsis
Idiopathic pulmonary fibrosis
Polypharmacy
Environmental impact of inhalers
Summary of recommendations for environmental considerations of respiratory prescribing
Inhaler prescribing
The most environmentally friendly inhaler is the one that the patient can, will and does use
Prescribing issues to consider
Area wide projects to promote inclusion of environmental focus for local formularies
CO2 emissions in Scotland
Case study
Scottish Therapeutics Utility (STU)
Resources for patients and clinicians
Purpose and context
Abbreviations
References
Back to the top
